http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1599197-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3e1ca7dd824f7f506dc8a931a3a2213
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91a2616e9099e1af509b8e348da666e3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
filingDate 2004-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b4773b6e653fd983326784b09048661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_795efe69bbc731ee625d80f97a1c473b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d4b39cc49fc32929702e404333daa0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c02ba32181015ce2550853d302058f0a
publicationDate 2005-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1599197-A2
titleOfInvention The use of antimuscarinic drugs
abstract The use of antimuscarinic drugs, biperiden in special, as a medication for preventing the onset of epilepsy that might ensue after the condition of status epileticus, major head trauma, including those occasioned by neurosurgical trauma, and acute lesional events to the brain.
priorityDate 2003-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129002180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129143706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129843440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID673473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426387251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12149109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135987176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425945

Total number of triples: 52.